Codagenix
Codagenix uses emerging computational and synthetic biology tools to rationally design vaccines.
Invested: 2020
Modality: Platform
Website: codagenix.com
portfolio
AN2 Therapeutics
AN2 Therapeutics is developing novel therapies for neglected diseases.
Invested: 2019
Modality: Small Molecule
Website: an2therapeutics.com
Themis
Themis is developing novel vaccines for high burden infectious diseases and oncology applications.
Invested: 2019
Modality: Vaccine
Website: themisbio.com
InDevR
InDevR is developing advanced characterization assays for biologics.
Invested: 2019
Modality: Process Innovation
Website: indevr.com